[STI571: the resistance organizes!].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D015195:Drug Design; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D005784:Gene Amplification; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence
STI571: la résistance s'organise!